Importantly, anti-tumor T cells are directed against tumor-associated antigens (gp100) but also against tumor neo-epitopes (B16-M30), and T cell activities elicited by WR/TK−/3Δ are significantly higher as compared with responses obtained with the non-treated group. This evidence concerns the gene PMEL and neoplasm.